Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer
Clinical trial NCT07637786 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07637786
- Sponsor
- Sichuan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-20
- Primary completion
- 2028-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.